| Symbol | ANIK |
|---|---|
| Name | ANIKA THERAPEUTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 32 WIGGINS AVENUE, BEDFORD, MA 01730 |
| Telephone | (781) 457-9000 |
| Fax | — |
| — | |
| Website | https://www.anika.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000898437 |
| Description | Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of revenue from the United States. Additional info from NASDAQ: |
📋 Jellison William R (Ex-Director) plans to sell 17K shares of Anika Therapeutics, Inc. (at $21.07 each, total $355K) Filed: Aug 07, 2026 | ID: 005793
Read moreNew Form SCHEDULE 13G/A - Anika Therapeutics, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0002100119-26-001342 <b>Size:</b> 7 KB
Read moreNew Form S-8 - Anika Therapeutics, Inc. <b>Filed:</b> 2026-07-29 <b>AccNo:</b> 0001171843-26-005017 <b>Size:</b> 192 KB
Read more(30% Negative) ANIKA THERAPEUTICS, INC. (ANIK) Reports Q3 2026 Financial Results
Read moreNew Form SCHEDULE 13G/A - Anika Therapeutics, Inc. <b>Filed:</b> 2026-07-17 <b>AccNo:</b> 0002052113-26-000740 <b>Size:</b> 11 KB
Read moreAnika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
Read moreAnika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
Read moreFischetti Gary P 🟢 acquired 10.4K shares of Anika Therapeutics, Inc. (ANIK) Transaction Date: Jun 18, 2026 | Filing ID: 279545
Read more